

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | oxaloacetate metabolic process (GO:0006107) | 4.35626946 |
| 2 | synaptic vesicle maturation (GO:0016188) | 4.29183246 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.24165995 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 4.22756747 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.94193896 |
| 6 | valine metabolic process (GO:0006573) | 3.87997553 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.86883421 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.85050755 |
| 9 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.71688763 |
| 10 | regulation of synapse structural plasticity (GO:0051823) | 3.69719373 |
| 11 | regulation of synaptic vesicle transport (GO:1902803) | 3.66698196 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.65208221 |
| 13 | glutamate secretion (GO:0014047) | 3.61570719 |
| 14 | NADH metabolic process (GO:0006734) | 3.56299607 |
| 15 | activation of protein kinase A activity (GO:0034199) | 3.46385589 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.45711991 |
| 17 | locomotory exploration behavior (GO:0035641) | 3.43207999 |
| 18 | ncRNA 3-end processing (GO:0043628) | 3.39119636 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.38950815 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.38950815 |
| 21 | ribosomal small subunit assembly (GO:0000028) | 3.35693216 |
| 22 | interkinetic nuclear migration (GO:0022027) | 3.30260229 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.29481373 |
| 24 | protein localization to synapse (GO:0035418) | 3.28189475 |
| 25 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.25042736 |
| 26 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.20701996 |
| 27 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.17227320 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.16883487 |
| 29 | neurotransmitter secretion (GO:0007269) | 3.15849116 |
| 30 | neuromuscular process controlling posture (GO:0050884) | 3.11678411 |
| 31 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.08181703 |
| 32 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.07125181 |
| 33 | Peyers patch development (GO:0048541) | 3.07125181 |
| 34 | oxygen transport (GO:0015671) | 3.01868755 |
| 35 | tricarboxylic acid metabolic process (GO:0072350) | 3.01077978 |
| 36 | positive regulation of membrane potential (GO:0045838) | 2.98089258 |
| 37 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.97076376 |
| 38 | histone H3-K4 trimethylation (GO:0080182) | 2.92771185 |
| 39 | mannose metabolic process (GO:0006013) | 2.89630453 |
| 40 | neuronal action potential propagation (GO:0019227) | 2.88792803 |
| 41 | positive regulation of histone deacetylation (GO:0031065) | 2.85607564 |
| 42 | positive regulation of protein deacetylation (GO:0090312) | 2.85584161 |
| 43 | succinate metabolic process (GO:0006105) | 2.84476033 |
| 44 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.84160679 |
| 45 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.83119480 |
| 46 | behavioral response to nicotine (GO:0035095) | 2.81840993 |
| 47 | regulation of female receptivity (GO:0045924) | 2.81048126 |
| 48 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.79253003 |
| 49 | cellular potassium ion homeostasis (GO:0030007) | 2.77662545 |
| 50 | detection of light stimulus involved in visual perception (GO:0050908) | 2.76569688 |
| 51 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.76569688 |
| 52 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.76089027 |
| 53 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.74679909 |
| 54 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.73524914 |
| 55 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.72950218 |
| 56 | necroptotic process (GO:0070266) | 2.70745176 |
| 57 | snRNA transcription (GO:0009301) | 2.70140771 |
| 58 | cellular response to ethanol (GO:0071361) | 2.69922193 |
| 59 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.69806648 |
| 60 | regulation of ARF protein signal transduction (GO:0032012) | 2.69429628 |
| 61 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.68516909 |
| 62 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.66718148 |
| 63 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.65375038 |
| 64 | synaptic transmission, glutamatergic (GO:0035249) | 2.64134908 |
| 65 | vocalization behavior (GO:0071625) | 2.63843536 |
| 66 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.62971328 |
| 67 | indolalkylamine metabolic process (GO:0006586) | 2.62358368 |
| 68 | positive regulation of synapse maturation (GO:0090129) | 2.61189386 |
| 69 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.59362753 |
| 70 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.56853826 |
| 71 | sodium ion export (GO:0071436) | 2.53716336 |
| 72 | neurotransmitter transport (GO:0006836) | 2.53516095 |
| 73 | regulation of neurotransmitter levels (GO:0001505) | 2.52900278 |
| 74 | negative regulation of microtubule polymerization (GO:0031115) | 2.51170577 |
| 75 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.50341382 |
| 76 | lymph node development (GO:0048535) | 2.49866271 |
| 77 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.49088130 |
| 78 | regulation of postsynaptic membrane potential (GO:0060078) | 2.48223284 |
| 79 | neuromuscular process controlling balance (GO:0050885) | 2.47431179 |
| 80 | regulation of ARF GTPase activity (GO:0032312) | 2.46420078 |
| 81 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.46267900 |
| 82 | pentose-phosphate shunt (GO:0006098) | 2.45463712 |
| 83 | indole-containing compound catabolic process (GO:0042436) | 2.44313817 |
| 84 | indolalkylamine catabolic process (GO:0046218) | 2.44313817 |
| 85 | tryptophan catabolic process (GO:0006569) | 2.44313817 |
| 86 | exploration behavior (GO:0035640) | 2.44218967 |
| 87 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.43369019 |
| 88 | positive regulation of B cell differentiation (GO:0045579) | 2.42724774 |
| 89 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.42576381 |
| 90 | nerve growth factor signaling pathway (GO:0038180) | 2.42104724 |
| 91 | response to histamine (GO:0034776) | 2.40688824 |
| 92 | dopamine receptor signaling pathway (GO:0007212) | 2.39829632 |
| 93 | regulation of gamma-delta T cell activation (GO:0046643) | 2.39521911 |
| 94 | T cell homeostasis (GO:0043029) | 2.39182206 |
| 95 | sodium-independent organic anion transport (GO:0043252) | 2.38621164 |
| 96 | neuron-neuron synaptic transmission (GO:0007270) | 2.38598168 |
| 97 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.38099492 |
| 98 | lactate metabolic process (GO:0006089) | 2.38026845 |
| 99 | clathrin coat assembly (GO:0048268) | 2.37720562 |
| 100 | regulation of defense response to virus by virus (GO:0050690) | 2.37472064 |
| 101 | L-fucose catabolic process (GO:0042355) | 2.37468034 |
| 102 | fucose catabolic process (GO:0019317) | 2.37468034 |
| 103 | L-fucose metabolic process (GO:0042354) | 2.37468034 |
| 104 | activated T cell proliferation (GO:0050798) | 2.36524899 |
| 105 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.35809785 |
| 106 | axon ensheathment in central nervous system (GO:0032291) | 2.35622102 |
| 107 | central nervous system myelination (GO:0022010) | 2.35622102 |
| 108 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.35469097 |
| 109 | cellular response to glucagon stimulus (GO:0071377) | 2.34977401 |
| 110 | gamma-aminobutyric acid transport (GO:0015812) | 2.34849401 |
| 111 | catecholamine transport (GO:0051937) | 2.34269323 |
| 112 | mast cell activation involved in immune response (GO:0002279) | 2.34105302 |
| 113 | mast cell degranulation (GO:0043303) | 2.34105302 |
| 114 | regulation of neurotransmitter secretion (GO:0046928) | 2.33543714 |
| 115 | 2-oxoglutarate metabolic process (GO:0006103) | 2.32865537 |
| 116 | cAMP catabolic process (GO:0006198) | 2.32425046 |
| 117 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.32037837 |
| 118 | positive regulation of developmental pigmentation (GO:0048087) | 2.30979432 |
| 119 | protein K48-linked deubiquitination (GO:0071108) | 2.30475944 |
| 120 | female mating behavior (GO:0060180) | 2.30459952 |
| 121 | membrane hyperpolarization (GO:0060081) | 2.30293743 |
| 122 | B cell receptor signaling pathway (GO:0050853) | 2.30237438 |
| 123 | membrane depolarization during action potential (GO:0086010) | 2.28851923 |
| 124 | NAD biosynthetic process (GO:0009435) | 2.28736071 |
| 125 | negative regulation of mast cell activation (GO:0033004) | 2.28157512 |
| 126 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.28011204 |
| 127 | positive regulation of neurotransmitter transport (GO:0051590) | 2.27862836 |
| 128 | cellular ketone body metabolic process (GO:0046950) | 2.27139568 |
| 129 | striated muscle atrophy (GO:0014891) | 2.25697363 |
| 130 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.25343122 |
| 131 | membrane depolarization (GO:0051899) | 2.25284554 |
| 132 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.24347153 |
| 133 | cellular extravasation (GO:0045123) | 2.24218271 |
| 134 | neurotransmitter uptake (GO:0001504) | 2.23559121 |
| 135 | corticosteroid receptor signaling pathway (GO:0031958) | 2.23462429 |
| 136 | synaptic vesicle endocytosis (GO:0048488) | 2.23112190 |
| 137 | adenosine receptor signaling pathway (GO:0001973) | 2.22842369 |
| 138 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.21678599 |
| 139 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.21597964 |
| 140 | regulation of histone deacetylation (GO:0031063) | 2.20702655 |
| 141 | opioid receptor signaling pathway (GO:0038003) | 2.19814171 |
| 142 | positive regulation of Rab GTPase activity (GO:0032851) | 2.17389816 |
| 143 | regulation of Rab GTPase activity (GO:0032313) | 2.17389816 |
| 144 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.16653042 |
| 145 | skeletal muscle adaptation (GO:0043501) | 2.15081430 |
| 146 | motile cilium assembly (GO:0044458) | 2.14682578 |
| 147 | pericardium development (GO:0060039) | 2.14322498 |
| 148 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.13786665 |
| 149 | cellular response to exogenous dsRNA (GO:0071360) | 2.13699904 |
| 150 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.11513622 |
| 151 | protein targeting to lysosome (GO:0006622) | 2.11504718 |
| 152 | establishment of protein localization to vacuole (GO:0072666) | 2.11504718 |
| 153 | protein targeting to vacuole (GO:0006623) | 2.11504718 |
| 154 | startle response (GO:0001964) | 2.09949375 |
| 155 | cyclic nucleotide catabolic process (GO:0009214) | 2.09936144 |
| 156 | negative regulation of cell killing (GO:0031342) | 2.09540219 |
| 157 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.09540219 |
| 158 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.09064972 |
| 159 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.08634726 |
| 160 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.06541068 |
| 161 | positive regulation of fatty acid oxidation (GO:0046321) | 2.05591421 |
| 162 | neuronal action potential (GO:0019228) | 2.03623196 |
| 163 | establishment of protein localization to Golgi (GO:0072600) | 2.02997571 |
| 164 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.00531502 |
| 165 | lytic vacuole organization (GO:0080171) | 1.99504932 |
| 166 | lysosome organization (GO:0007040) | 1.99504932 |
| 167 | myofibril assembly (GO:0030239) | 1.99353102 |
| 168 | regulation of cilium assembly (GO:1902017) | 1.99246586 |
| 169 | negative regulation of granulocyte differentiation (GO:0030853) | 1.98985198 |
| 170 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 1.98939641 |
| 171 | phospholipid translocation (GO:0045332) | 1.98178998 |
| 172 | lipid translocation (GO:0034204) | 1.98178998 |
| 173 | tryptophan metabolic process (GO:0006568) | 1.97582577 |
| 174 | primary amino compound metabolic process (GO:1901160) | 1.97476593 |
| 175 | regulation of protein deacetylation (GO:0090311) | 1.96845177 |
| 176 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 1.96799259 |
| 177 | lymphangiogenesis (GO:0001946) | 1.96598034 |
| 178 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 1.96155474 |
| 179 | negative regulation of T-helper cell differentiation (GO:0045623) | 1.96155474 |
| 180 | positive regulation of phosphatase activity (GO:0010922) | 1.95780245 |
| 181 | transmission of nerve impulse (GO:0019226) | 1.94795936 |
| 182 | mature B cell differentiation (GO:0002335) | 1.94650055 |
| 183 | positive regulation of protein kinase C signaling (GO:0090037) | 1.94151813 |
| 184 | negative regulation of erythrocyte differentiation (GO:0045647) | 1.93484114 |
| 185 | skeletal muscle tissue regeneration (GO:0043403) | 1.92805891 |
| 186 | nucleus localization (GO:0051647) | 1.92188144 |
| 187 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 1.91954681 |
| 188 | regulation of action potential (GO:0098900) | 1.91669802 |
| 189 | negative regulation of myotube differentiation (GO:0010832) | 1.91648617 |
| 190 | indole-containing compound metabolic process (GO:0042430) | 1.90284407 |
| 191 | regulation of cAMP-mediated signaling (GO:0043949) | 1.89911110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 3.46890477 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.30262573 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.07560284 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.71910740 |
| 5 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.54384997 |
| 6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.52403074 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.50177404 |
| 8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.48022124 |
| 9 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.45037925 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.35305892 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.27575060 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.23932554 |
| 13 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.16328492 |
| 14 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.14131973 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.04713684 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.02501168 |
| 17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.01586759 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.94476047 |
| 19 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.92414011 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.91807285 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91394153 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.91285876 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.90497199 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.89952282 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.89809856 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.83759779 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82815731 |
| 28 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.73692299 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69321707 |
| 30 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.67633914 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67068323 |
| 32 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.65332052 |
| 33 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.65008029 |
| 34 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62922165 |
| 35 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.60383922 |
| 36 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.59222532 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.58341692 |
| 38 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.57477726 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56992537 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55085536 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52763745 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.52537025 |
| 43 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.52418786 |
| 44 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.52374831 |
| 45 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.51339013 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.48888215 |
| 47 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.48711364 |
| 48 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.48129331 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.45685368 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45217910 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44753893 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44328680 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44203547 |
| 54 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.43460821 |
| 55 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.43151739 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.42345887 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40542050 |
| 58 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.40174927 |
| 59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39487656 |
| 60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39312905 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.38624981 |
| 62 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.38402123 |
| 63 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.38312817 |
| 64 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.37462156 |
| 65 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.37430203 |
| 66 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.36420161 |
| 67 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.35757880 |
| 68 | MAF_26560356_Chip-Seq_TH1_Human | 1.34429815 |
| 69 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.31923094 |
| 70 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.30268623 |
| 71 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.29833632 |
| 72 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29549549 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.27792455 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27345628 |
| 75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.27269894 |
| 76 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.27229036 |
| 77 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25485660 |
| 78 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25174762 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24582555 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.23392644 |
| 81 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.23166054 |
| 82 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.21764657 |
| 83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.21686199 |
| 84 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.19656926 |
| 85 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.19656926 |
| 86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19082597 |
| 87 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19045373 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18952030 |
| 89 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.18061808 |
| 90 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.17585349 |
| 91 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16414263 |
| 92 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.16263806 |
| 93 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.14344956 |
| 94 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14206194 |
| 95 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13663622 |
| 96 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.13447884 |
| 97 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13143166 |
| 98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12806590 |
| 99 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12495771 |
| 100 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11807321 |
| 101 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.11380407 |
| 102 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.11325572 |
| 103 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11214317 |
| 104 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10989477 |
| 105 | P68_20966046_ChIP-Seq_HELA_Human | 1.10536694 |
| 106 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10195218 |
| 107 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.09847704 |
| 108 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.09327044 |
| 109 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07779573 |
| 110 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07779573 |
| 111 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.06867678 |
| 112 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.06589683 |
| 113 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05772258 |
| 114 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05651803 |
| 115 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05549611 |
| 116 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05002340 |
| 117 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04095217 |
| 118 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.02487513 |
| 119 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.01495697 |
| 120 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01252084 |
| 121 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.01193083 |
| 122 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01012252 |
| 123 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00703711 |
| 124 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.00660913 |
| 125 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00551308 |
| 126 | AR_19668381_ChIP-Seq_PC3_Human | 0.99868157 |
| 127 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99644863 |
| 128 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.99308964 |
| 129 | MAF_26560356_Chip-Seq_TH2_Human | 0.99257507 |
| 130 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98665335 |
| 131 | MYB_26560356_Chip-Seq_TH1_Human | 0.98451977 |
| 132 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98442532 |
| 133 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.98345015 |
| 134 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98044081 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97540669 |
| 136 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.97453204 |
| 137 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96063492 |
| 138 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95735205 |
| 139 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.95508463 |
| 140 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95007760 |
| 141 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94640081 |
| 142 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94048293 |
| 143 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93930532 |
| 144 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.93739158 |
| 145 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.93682766 |
| 146 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.93319587 |
| 147 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93046580 |
| 148 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.93023997 |
| 149 | TCF4_23295773_ChIP-Seq_U87_Human | 0.92461041 |
| 150 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.91970669 |
| 151 | MYB_26560356_Chip-Seq_TH2_Human | 0.91896288 |
| 152 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90606701 |
| 153 | ERA_21632823_ChIP-Seq_H3396_Human | 0.87687684 |
| 154 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86945158 |
| 155 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.84917630 |
| 156 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84146355 |
| 157 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.83012420 |
| 158 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82593735 |
| 159 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.82588203 |
| 160 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.82113107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.63254425 |
| 2 | MP0003646_muscle_fatigue | 3.42475011 |
| 3 | MP0002653_abnormal_ependyma_morphology | 3.25067923 |
| 4 | MP0003880_abnormal_central_pattern | 3.12925169 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.07320480 |
| 6 | MP0002822_catalepsy | 2.78533850 |
| 7 | MP0009745_abnormal_behavioral_response | 2.57362856 |
| 8 | MP0002064_seizures | 2.56464999 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.43813568 |
| 10 | MP0002736_abnormal_nociception_after | 2.35462705 |
| 11 | MP0004270_analgesia | 2.29804141 |
| 12 | MP0009046_muscle_twitch | 2.24094030 |
| 13 | MP0008872_abnormal_physiological_respon | 2.22764551 |
| 14 | MP0003656_abnormal_erythrocyte_physiolo | 2.17120638 |
| 15 | MP0002272_abnormal_nervous_system | 2.12532788 |
| 16 | MP0002063_abnormal_learning/memory/cond | 2.03619174 |
| 17 | MP0005670_abnormal_white_adipose | 1.98176551 |
| 18 | MP0003329_amyloid_beta_deposits | 1.94231054 |
| 19 | MP0002928_abnormal_bile_duct | 1.86971740 |
| 20 | MP0001545_abnormal_hematopoietic_system | 1.86472358 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 1.86472358 |
| 22 | MP0004381_abnormal_hair_follicle | 1.85693934 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.82412046 |
| 24 | MP0006276_abnormal_autonomic_nervous | 1.80893727 |
| 25 | MP0005409_darkened_coat_color | 1.80839042 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 1.79689977 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.78987290 |
| 28 | MP0004147_increased_porphyrin_level | 1.77992983 |
| 29 | MP0002396_abnormal_hematopoietic_system | 1.76499767 |
| 30 | MP0004145_abnormal_muscle_electrophysio | 1.69511989 |
| 31 | MP0002735_abnormal_chemical_nociception | 1.65709096 |
| 32 | MP0005423_abnormal_somatic_nervous | 1.63791580 |
| 33 | MP0003045_fibrosis | 1.62478147 |
| 34 | MP0005365_abnormal_bile_salt | 1.61131426 |
| 35 | MP0003787_abnormal_imprinting | 1.59119570 |
| 36 | MP0003195_calcinosis | 1.58092142 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.54691605 |
| 38 | MP0002734_abnormal_mechanical_nocicepti | 1.53990586 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.50456146 |
| 40 | MP0008569_lethality_at_weaning | 1.49767716 |
| 41 | MP0001800_abnormal_humoral_immune | 1.46670272 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.44860166 |
| 43 | MP0000685_abnormal_immune_system | 1.42696576 |
| 44 | MP0004043_abnormal_pH_regulation | 1.39493832 |
| 45 | MP0001790_abnormal_immune_system | 1.38009223 |
| 46 | MP0005387_immune_system_phenotype | 1.38009223 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.37594122 |
| 48 | MP0005310_abnormal_salivary_gland | 1.34885091 |
| 49 | MP0004924_abnormal_behavior | 1.31980386 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.31980386 |
| 51 | MP0008874_decreased_physiological_sensi | 1.31257276 |
| 52 | MP0002139_abnormal_hepatobiliary_system | 1.30292200 |
| 53 | MP0003763_abnormal_thymus_physiology | 1.30197853 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.29902165 |
| 55 | MP0001970_abnormal_pain_threshold | 1.29488189 |
| 56 | MP0001486_abnormal_startle_reflex | 1.29278988 |
| 57 | MP0009840_abnormal_foam_cell | 1.29050749 |
| 58 | MP0000747_muscle_weakness | 1.28787467 |
| 59 | MP0000604_amyloidosis | 1.28066610 |
| 60 | MP0000230_abnormal_systemic_arterial | 1.26477601 |
| 61 | MP0003436_decreased_susceptibility_to | 1.23725115 |
| 62 | MP0003878_abnormal_ear_physiology | 1.23483392 |
| 63 | MP0005377_hearing/vestibular/ear_phenot | 1.23483392 |
| 64 | MP0002067_abnormal_sensory_capabilities | 1.21541197 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.21003696 |
| 66 | MP0005645_abnormal_hypothalamus_physiol | 1.21002285 |
| 67 | MP0005464_abnormal_platelet_physiology | 1.20933892 |
| 68 | MP0002733_abnormal_thermal_nociception | 1.20033488 |
| 69 | MP0000751_myopathy | 1.19960208 |
| 70 | MP0000569_abnormal_digit_pigmentation | 1.16742904 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 1.15117490 |
| 72 | MP0003633_abnormal_nervous_system | 1.15029226 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.14026835 |
| 74 | MP0001873_stomach_inflammation | 1.13216300 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 1.13146788 |
| 76 | MP0001986_abnormal_taste_sensitivity | 1.11803986 |
| 77 | MP0003866_abnormal_defecation | 1.11269933 |
| 78 | MP0004142_abnormal_muscle_tone | 1.11186769 |
| 79 | MP0004742_abnormal_vestibular_system | 1.10518051 |
| 80 | MP0000015_abnormal_ear_pigmentation | 1.08521118 |
| 81 | MP0002398_abnormal_bone_marrow | 1.08180376 |
| 82 | MP0004036_abnormal_muscle_relaxation | 1.06114759 |
| 83 | MP0000371_diluted_coat_color | 1.05556626 |
| 84 | MP0000013_abnormal_adipose_tissue | 1.05414811 |
| 85 | MP0001529_abnormal_vocalization | 1.05267330 |
| 86 | MP0003868_abnormal_feces_composition | 1.05174034 |
| 87 | MP0009278_abnormal_bone_marrow | 1.03713753 |
| 88 | MP0005535_abnormal_body_temperature | 1.02174085 |
| 89 | MP0001348_abnormal_lacrimal_gland | 1.01597769 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 1.01398395 |
| 91 | MP0002229_neurodegeneration | 0.99824826 |
| 92 | MP0003724_increased_susceptibility_to | 0.99795685 |
| 93 | MP0002419_abnormal_innate_immunity | 0.98139174 |
| 94 | MP0006035_abnormal_mitochondrial_morpho | 0.97725137 |
| 95 | MP0003879_abnormal_hair_cell | 0.97017843 |
| 96 | MP0002971_abnormal_brown_adipose | 0.96128280 |
| 97 | MP0002933_joint_inflammation | 0.95762186 |
| 98 | MP0001502_abnormal_circadian_rhythm | 0.95450456 |
| 99 | MP0002066_abnormal_motor_capabilities/c | 0.94617752 |
| 100 | MP0008877_abnormal_DNA_methylation | 0.94417623 |
| 101 | MP0002837_dystrophic_cardiac_calcinosis | 0.94208113 |
| 102 | MP0002168_other_aberrant_phenotype | 0.93700124 |
| 103 | MP0002723_abnormal_immune_serum | 0.93271812 |
| 104 | MP0000703_abnormal_thymus_morphology | 0.92895630 |
| 105 | MP0004130_abnormal_muscle_cell | 0.92410526 |
| 106 | MP0003221_abnormal_cardiomyocyte_apopto | 0.92256398 |
| 107 | MP0001501_abnormal_sleep_pattern | 0.91866266 |
| 108 | MP0005025_abnormal_response_to | 0.91701537 |
| 109 | MP0005360_urolithiasis | 0.90604237 |
| 110 | MP0009384_cardiac_valve_regurgitation | 0.90556372 |
| 111 | MP0004885_abnormal_endolymph | 0.90090995 |
| 112 | MP0002557_abnormal_social/conspecific_i | 0.89077377 |
| 113 | MP0000689_abnormal_spleen_morphology | 0.88916039 |
| 114 | MP0001958_emphysema | 0.87918166 |
| 115 | MP0000920_abnormal_myelination | 0.87515710 |
| 116 | MP0005551_abnormal_eye_electrophysiolog | 0.87472053 |
| 117 | MP0005174_abnormal_tail_pigmentation | 0.86885804 |
| 118 | MP0003631_nervous_system_phenotype | 0.86516905 |
| 119 | MP0001905_abnormal_dopamine_level | 0.85453683 |
| 120 | MP0002166_altered_tumor_susceptibility | 0.83452604 |
| 121 | MP0002722_abnormal_immune_system | 0.83216928 |
| 122 | MP0002420_abnormal_adaptive_immunity | 0.83118251 |
| 123 | MP0002882_abnormal_neuron_morphology | 0.82920134 |
| 124 | MP0003075_altered_response_to | 0.82820779 |
| 125 | MP0003690_abnormal_glial_cell | 0.82503780 |
| 126 | MP0005166_decreased_susceptibility_to | 0.82244575 |
| 127 | MP0002452_abnormal_antigen_presenting | 0.80941872 |
| 128 | MP0000470_abnormal_stomach_morphology | 0.80771560 |
| 129 | MP0000955_abnormal_spinal_cord | 0.80768413 |
| 130 | MP0001819_abnormal_immune_cell | 0.79306882 |
| 131 | MP0001765_abnormal_ion_homeostasis | 0.78997657 |
| 132 | MP0001835_abnormal_antigen_presentation | 0.78687876 |
| 133 | MP0003806_abnormal_nucleotide_metabolis | 0.78073386 |
| 134 | MP0001764_abnormal_homeostasis | 0.77400660 |
| 135 | MP0008961_abnormal_basal_metabolism | 0.76626378 |
| 136 | MP0005448_abnormal_energy_balance | 0.76581345 |
| 137 | MP0010329_abnormal_lipoprotein_level | 0.75722039 |
| 138 | MP0005266_abnormal_metabolism | 0.74865040 |
| 139 | MP0002118_abnormal_lipid_homeostasis | 0.74838751 |
| 140 | MP0005075_abnormal_melanosome_morpholog | 0.74516915 |
| 141 | MP0004133_heterotaxia | 0.74048402 |
| 142 | MP0001663_abnormal_digestive_system | 0.74032682 |
| 143 | MP0000716_abnormal_immune_system | 0.73324297 |
| 144 | MP0003303_peritoneal_inflammation | 0.73170949 |
| 145 | MP0005000_abnormal_immune_tolerance | 0.72893736 |
| 146 | MP0001963_abnormal_hearing_physiology | 0.72679238 |
| 147 | MP0002405_respiratory_system_inflammati | 0.72027130 |
| 148 | MP0004858_abnormal_nervous_system | 0.71599551 |
| 149 | MP0002693_abnormal_pancreas_physiology | 0.70664661 |
| 150 | MP0003943_abnormal_hepatobiliary_system | 0.70108127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Genetic anticipation (HP:0003743) | 4.55229213 |
| 2 | Myokymia (HP:0002411) | 4.23090523 |
| 3 | Ankle clonus (HP:0011448) | 4.21358184 |
| 4 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.06842356 |
| 5 | Absent/shortened dynein arms (HP:0200106) | 4.06842356 |
| 6 | Hyperventilation (HP:0002883) | 3.81705641 |
| 7 | Thrombocytosis (HP:0001894) | 3.75410607 |
| 8 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.69328329 |
| 9 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.65339012 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.59128623 |
| 11 | Visual hallucinations (HP:0002367) | 3.56097908 |
| 12 | Spastic gait (HP:0002064) | 3.51255122 |
| 13 | Clonus (HP:0002169) | 3.35412452 |
| 14 | Papilledema (HP:0001085) | 3.25852328 |
| 15 | Focal motor seizures (HP:0011153) | 3.06432054 |
| 16 | Protruding tongue (HP:0010808) | 3.04853077 |
| 17 | Epileptic encephalopathy (HP:0200134) | 2.99358947 |
| 18 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.97630107 |
| 19 | Clumsiness (HP:0002312) | 2.95420035 |
| 20 | Fatigue (HP:0012378) | 2.90149968 |
| 21 | Postural instability (HP:0002172) | 2.87367436 |
| 22 | Febrile seizures (HP:0002373) | 2.85065945 |
| 23 | Abnormal ciliary motility (HP:0012262) | 2.84460594 |
| 24 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.83535240 |
| 25 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.83535240 |
| 26 | Supranuclear gaze palsy (HP:0000605) | 2.80222439 |
| 27 | Abnormality of the periventricular white matter (HP:0002518) | 2.75992584 |
| 28 | Anxiety (HP:0000739) | 2.75515460 |
| 29 | Aplastic anemia (HP:0001915) | 2.73581046 |
| 30 | Impaired vibratory sensation (HP:0002495) | 2.70861778 |
| 31 | Resting tremor (HP:0002322) | 2.65553255 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.65166495 |
| 33 | Urinary urgency (HP:0000012) | 2.64404113 |
| 34 | Hypoplasia of the thymus (HP:0000778) | 2.59914872 |
| 35 | Congenital stationary night blindness (HP:0007642) | 2.54810753 |
| 36 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.52300808 |
| 37 | Depression (HP:0000716) | 2.49079917 |
| 38 | Focal seizures (HP:0007359) | 2.48387435 |
| 39 | Nephronophthisis (HP:0000090) | 2.47972195 |
| 40 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.47534823 |
| 41 | Lower limb muscle weakness (HP:0007340) | 2.43865066 |
| 42 | Impaired social interactions (HP:0000735) | 2.40911956 |
| 43 | Abnormal social behavior (HP:0012433) | 2.40911956 |
| 44 | Truncal ataxia (HP:0002078) | 2.38601128 |
| 45 | Death in childhood (HP:0003819) | 2.37346702 |
| 46 | Chronic hepatic failure (HP:0100626) | 2.36144852 |
| 47 | Chronic otitis media (HP:0000389) | 2.35526228 |
| 48 | Poor eye contact (HP:0000817) | 2.35510771 |
| 49 | Myositis (HP:0100614) | 2.34656288 |
| 50 | Molar tooth sign on MRI (HP:0002419) | 2.33478653 |
| 51 | Abnormality of midbrain morphology (HP:0002418) | 2.33478653 |
| 52 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.32482348 |
| 53 | Abnormal drinking behavior (HP:0030082) | 2.31782220 |
| 54 | Polydipsia (HP:0001959) | 2.31782220 |
| 55 | Scanning speech (HP:0002168) | 2.31326768 |
| 56 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.31190414 |
| 57 | Attenuation of retinal blood vessels (HP:0007843) | 2.29746176 |
| 58 | Insomnia (HP:0100785) | 2.29376717 |
| 59 | Abnormality of the lower motor neuron (HP:0002366) | 2.27542479 |
| 60 | Decreased circulating renin level (HP:0003351) | 2.27508701 |
| 61 | Recurrent fungal infections (HP:0002841) | 2.25489971 |
| 62 | Abnormality of the fingertips (HP:0001211) | 2.24752456 |
| 63 | Recurrent sinusitis (HP:0011108) | 2.24589808 |
| 64 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.23743530 |
| 65 | Bradykinesia (HP:0002067) | 2.22612893 |
| 66 | Poor suck (HP:0002033) | 2.22254046 |
| 67 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.21443752 |
| 68 | Focal dystonia (HP:0004373) | 2.20124396 |
| 69 | Macroglossia (HP:0000158) | 2.17466330 |
| 70 | Abnormality of the renal medulla (HP:0100957) | 2.17061892 |
| 71 | Tetraplegia (HP:0002445) | 2.15279393 |
| 72 | Dysmetria (HP:0001310) | 2.14442992 |
| 73 | Craniofacial dystonia (HP:0012179) | 2.13911707 |
| 74 | Cystic liver disease (HP:0006706) | 2.13632015 |
| 75 | Obstructive sleep apnea (HP:0002870) | 2.13608716 |
| 76 | Bulbous nose (HP:0000414) | 2.12834911 |
| 77 | Orchitis (HP:0100796) | 2.11413277 |
| 78 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.10347259 |
| 79 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.10145006 |
| 80 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.09864809 |
| 81 | Nasal polyposis (HP:0100582) | 2.09462796 |
| 82 | Keratoconjunctivitis (HP:0001096) | 2.06986013 |
| 83 | Cholecystitis (HP:0001082) | 2.05889145 |
| 84 | Abnormal gallbladder physiology (HP:0012438) | 2.05889145 |
| 85 | Gaze-evoked nystagmus (HP:0000640) | 2.04537223 |
| 86 | Progressive microcephaly (HP:0000253) | 2.03353624 |
| 87 | Increased variability in muscle fiber diameter (HP:0003557) | 2.03062618 |
| 88 | Keratoconjunctivitis sicca (HP:0001097) | 2.01235635 |
| 89 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.00794650 |
| 90 | Psychosis (HP:0000709) | 1.99239525 |
| 91 | Severe global developmental delay (HP:0011344) | 1.98498117 |
| 92 | Absent speech (HP:0001344) | 1.98366469 |
| 93 | Prolonged QT interval (HP:0001657) | 1.97741393 |
| 94 | Hyperacusis (HP:0010780) | 1.97126446 |
| 95 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96924464 |
| 96 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96924464 |
| 97 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96924464 |
| 98 | Epileptiform EEG discharges (HP:0011182) | 1.95463337 |
| 99 | Colitis (HP:0002583) | 1.95382615 |
| 100 | Lymphangioma (HP:0100764) | 1.94546946 |
| 101 | Rigidity (HP:0002063) | 1.94473748 |
| 102 | CNS hypomyelination (HP:0003429) | 1.94410125 |
| 103 | EEG with generalized epileptiform discharges (HP:0011198) | 1.94394208 |
| 104 | Recurrent bronchitis (HP:0002837) | 1.93738338 |
| 105 | Abnormality of binocular vision (HP:0011514) | 1.90443775 |
| 106 | Diplopia (HP:0000651) | 1.90443775 |
| 107 | Ragged-red muscle fibers (HP:0003200) | 1.89817865 |
| 108 | Increased cerebral lipofuscin (HP:0011813) | 1.89762301 |
| 109 | Retrobulbar optic neuritis (HP:0100654) | 1.89728021 |
| 110 | Optic neuritis (HP:0100653) | 1.89728021 |
| 111 | Menstrual irregularities (HP:0000858) | 1.88955517 |
| 112 | Polygenic inheritance (HP:0010982) | 1.88905456 |
| 113 | Spontaneous hematomas (HP:0007420) | 1.87640246 |
| 114 | Generalized tonic-clonic seizures (HP:0002069) | 1.87637194 |
| 115 | Torticollis (HP:0000473) | 1.87578529 |
| 116 | Hyperkalemia (HP:0002153) | 1.87415562 |
| 117 | Growth hormone excess (HP:0000845) | 1.87193640 |
| 118 | Exercise-induced myalgia (HP:0003738) | 1.86879085 |
| 119 | Hypoplastic ischia (HP:0003175) | 1.86739005 |
| 120 | Decreased central vision (HP:0007663) | 1.86725168 |
| 121 | Recurrent cutaneous fungal infections (HP:0011370) | 1.86525940 |
| 122 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.86525940 |
| 123 | Mucopolysacchariduria (HP:0008155) | 1.86097224 |
| 124 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86097224 |
| 125 | Abnormality of pain sensation (HP:0010832) | 1.85875621 |
| 126 | Impaired pain sensation (HP:0007328) | 1.85875621 |
| 127 | Impaired smooth pursuit (HP:0007772) | 1.85757457 |
| 128 | Stereotypic behavior (HP:0000733) | 1.84975381 |
| 129 | Hypsarrhythmia (HP:0002521) | 1.84882628 |
| 130 | Widely spaced teeth (HP:0000687) | 1.84110435 |
| 131 | Pancreatic cysts (HP:0001737) | 1.84002080 |
| 132 | Mesangial abnormality (HP:0001966) | 1.83763247 |
| 133 | IgM deficiency (HP:0002850) | 1.83435014 |
| 134 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.83006968 |
| 135 | Insidious onset (HP:0003587) | 1.82952843 |
| 136 | Termporal pattern (HP:0011008) | 1.82952843 |
| 137 | Abnormality of the corticospinal tract (HP:0002492) | 1.82949014 |
| 138 | Inflammation of the large intestine (HP:0002037) | 1.82933416 |
| 139 | Peritonitis (HP:0002586) | 1.82378612 |
| 140 | Ankyloglossia (HP:0010296) | 1.82171886 |
| 141 | Neonatal hypoglycemia (HP:0001998) | 1.82008142 |
| 142 | Congenital sensorineural hearing impairment (HP:0008527) | 1.81416279 |
| 143 | Hypoglycemic coma (HP:0001325) | 1.81244539 |
| 144 | Cortical visual impairment (HP:0100704) | 1.81227057 |
| 145 | Dysmetric saccades (HP:0000641) | 1.81123575 |
| 146 | Dysostosis multiplex (HP:0000943) | 1.81001545 |
| 147 | Atonic seizures (HP:0010819) | 1.80997335 |
| 148 | Progressive inability to walk (HP:0002505) | 1.80145283 |
| 149 | Abnormality of the nasal mucosa (HP:0000433) | 1.79879280 |
| 150 | Tapered finger (HP:0001182) | 1.79429835 |
| 151 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.79328264 |
| 152 | Panhypogammaglobulinemia (HP:0003139) | 1.79104132 |
| 153 | Delusions (HP:0000746) | 1.78826860 |
| 154 | Annular pancreas (HP:0001734) | 1.78084075 |
| 155 | Brushfield spots (HP:0001088) | 1.77823884 |
| 156 | Abnormality of oral frenula (HP:0000190) | 1.77498532 |
| 157 | Tented upper lip vermilion (HP:0010804) | 1.77321839 |
| 158 | Cerebral hypomyelination (HP:0006808) | 1.77002401 |
| 159 | Pigmentary retinal degeneration (HP:0001146) | 1.76982493 |
| 160 | Portal hypertension (HP:0001409) | 1.76684454 |
| 161 | Abnormality of the hepatic vasculature (HP:0006707) | 1.76106309 |
| 162 | Anomalous pulmonary venous return (HP:0010772) | 1.76038676 |
| 163 | Hemiplegia (HP:0002301) | 1.75806191 |
| 164 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.75613978 |
| 165 | Absence seizures (HP:0002121) | 1.75565121 |
| 166 | Congenital hepatic fibrosis (HP:0002612) | 1.74819617 |
| 167 | Asymmetric septal hypertrophy (HP:0001670) | 1.74082224 |
| 168 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.74073655 |
| 169 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.74072939 |
| 170 | Agammaglobulinemia (HP:0004432) | 1.73581397 |
| 171 | True hermaphroditism (HP:0010459) | 1.73127126 |
| 172 | Tubular atrophy (HP:0000092) | 1.73114814 |
| 173 | Intellectual disability, severe (HP:0010864) | 1.72912866 |
| 174 | Acute lymphatic leukemia (HP:0006721) | 1.72803658 |
| 175 | Generalized aminoaciduria (HP:0002909) | 1.72355071 |
| 176 | Inability to walk (HP:0002540) | 1.71795888 |
| 177 | Keratoconus (HP:0000563) | 1.71568216 |
| 178 | Increased corneal curvature (HP:0100692) | 1.71568216 |
| 179 | Ketosis (HP:0001946) | 1.71527521 |
| 180 | Recurrent bacterial skin infections (HP:0005406) | 1.71397462 |
| 181 | Eczematoid dermatitis (HP:0000976) | 1.71261874 |
| 182 | Oligomenorrhea (HP:0000876) | 1.71105345 |
| 183 | Hypoplasia of the pons (HP:0012110) | 1.70843027 |
| 184 | Broad-based gait (HP:0002136) | 1.70438981 |
| 185 | Action tremor (HP:0002345) | 1.69067349 |
| 186 | Hyperbilirubinemia (HP:0002904) | 1.67970426 |
| 187 | Gastrointestinal inflammation (HP:0004386) | 1.66536960 |
| 188 | Truncal obesity (HP:0001956) | 1.66266432 |
| 189 | Agitation (HP:0000713) | 1.64931586 |
| 190 | Pancreatic fibrosis (HP:0100732) | 1.63875619 |
| 191 | Abnormal EKG (HP:0003115) | 1.63503924 |
| 192 | Prolonged bleeding time (HP:0003010) | 1.62962454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K4 | 4.90839371 |
| 2 | FRK | 4.71149290 |
| 3 | MAP2K7 | 4.61511920 |
| 4 | MAP2K4 | 3.49111866 |
| 5 | MAP4K1 | 2.75178624 |
| 6 | NTRK3 | 2.60189101 |
| 7 | CDK19 | 2.46593772 |
| 8 | BLK | 2.11732278 |
| 9 | MAP3K9 | 2.10900797 |
| 10 | EPHA4 | 2.10106237 |
| 11 | CAMKK2 | 2.08321667 |
| 12 | MINK1 | 1.89770677 |
| 13 | BCKDK | 1.86739639 |
| 14 | CAMK1D | 1.79701551 |
| 15 | CCNB1 | 1.75679844 |
| 16 | DAPK1 | 1.75317178 |
| 17 | CDC42BPA | 1.69374331 |
| 18 | CAMKK1 | 1.67856846 |
| 19 | RET | 1.59413314 |
| 20 | CAMK1G | 1.58021203 |
| 21 | CDK8 | 1.57785194 |
| 22 | EEF2K | 1.57459822 |
| 23 | DAPK2 | 1.57047876 |
| 24 | MAP3K12 | 1.56956734 |
| 25 | FES | 1.56659989 |
| 26 | MAP3K13 | 1.48933897 |
| 27 | MAP3K11 | 1.35115175 |
| 28 | MAPK13 | 1.34022767 |
| 29 | ZAP70 | 1.33785786 |
| 30 | PRKD3 | 1.32713343 |
| 31 | STK16 | 1.30595131 |
| 32 | INSRR | 1.24420410 |
| 33 | MAP2K2 | 1.23279202 |
| 34 | TSSK6 | 1.17978541 |
| 35 | TNK2 | 1.17436833 |
| 36 | SYK | 1.16727475 |
| 37 | NTRK2 | 1.16524072 |
| 38 | MAPK12 | 1.15988163 |
| 39 | ADRBK2 | 1.12555352 |
| 40 | TAOK3 | 1.11484676 |
| 41 | TAOK1 | 1.10119754 |
| 42 | BTK | 1.09750376 |
| 43 | KSR2 | 1.08330700 |
| 44 | CAMK1 | 1.07554541 |
| 45 | MAPK15 | 1.07065638 |
| 46 | TXK | 1.04747995 |
| 47 | STK38 | 1.04218792 |
| 48 | CDK5 | 1.03380372 |
| 49 | PIK3CG | 1.02737150 |
| 50 | CDK3 | 1.02084711 |
| 51 | FLT3 | 1.01043391 |
| 52 | PKN2 | 1.00994341 |
| 53 | PDK1 | 1.00715178 |
| 54 | GRK6 | 1.00580273 |
| 55 | TYK2 | 0.97287553 |
| 56 | SGK2 | 0.96131659 |
| 57 | RPS6KA2 | 0.95992137 |
| 58 | CDK12 | 0.93766853 |
| 59 | RPS6KA6 | 0.93443057 |
| 60 | MAP2K6 | 0.89676047 |
| 61 | KIT | 0.88392262 |
| 62 | PRKCH | 0.88082374 |
| 63 | PRKAA2 | 0.86699295 |
| 64 | UHMK1 | 0.84831467 |
| 65 | MAP3K6 | 0.83112546 |
| 66 | NEK1 | 0.82321768 |
| 67 | TYRO3 | 0.81693462 |
| 68 | ADRBK1 | 0.81285729 |
| 69 | CSF1R | 0.80367639 |
| 70 | PASK | 0.79849386 |
| 71 | SGK3 | 0.79651028 |
| 72 | SIK2 | 0.79298464 |
| 73 | RPS6KC1 | 0.78688829 |
| 74 | RPS6KL1 | 0.78688829 |
| 75 | ACVR1B | 0.77756871 |
| 76 | IRAK4 | 0.77596752 |
| 77 | CSNK1G3 | 0.75628062 |
| 78 | PAK6 | 0.75107656 |
| 79 | SCYL2 | 0.74355224 |
| 80 | JAK2 | 0.73758798 |
| 81 | TRIB3 | 0.73463063 |
| 82 | ICK | 0.73348388 |
| 83 | OBSCN | 0.73163879 |
| 84 | NTRK1 | 0.70926333 |
| 85 | EIF2AK1 | 0.70708151 |
| 86 | PDK3 | 0.69397712 |
| 87 | PDK4 | 0.69397712 |
| 88 | MAPKAPK3 | 0.68878541 |
| 89 | ALK | 0.68589331 |
| 90 | EPHB1 | 0.67339208 |
| 91 | ITK | 0.67157411 |
| 92 | MAP3K7 | 0.66858602 |
| 93 | MARK2 | 0.66667977 |
| 94 | MAPK11 | 0.65733044 |
| 95 | MUSK | 0.65380411 |
| 96 | IRAK1 | 0.65021961 |
| 97 | PTK6 | 0.64174483 |
| 98 | RAF1 | 0.63248869 |
| 99 | MAP2K3 | 0.62842297 |
| 100 | MAPK7 | 0.62081012 |
| 101 | LMTK2 | 0.62064242 |
| 102 | FGFR3 | 0.62062899 |
| 103 | TTN | 0.61941298 |
| 104 | CAMK4 | 0.61372682 |
| 105 | GRK1 | 0.60913407 |
| 106 | WNK4 | 0.59900798 |
| 107 | CSNK1G2 | 0.59281880 |
| 108 | MTOR | 0.59150225 |
| 109 | PRKAA1 | 0.58621178 |
| 110 | PRKCZ | 0.58416314 |
| 111 | PRKCQ | 0.58145543 |
| 112 | MAP2K1 | 0.57373691 |
| 113 | KSR1 | 0.57280969 |
| 114 | WNK1 | 0.56700200 |
| 115 | TGFBR1 | 0.56629381 |
| 116 | EPHA3 | 0.56472721 |
| 117 | PINK1 | 0.55767521 |
| 118 | SGK1 | 0.55028334 |
| 119 | HCK | 0.54729313 |
| 120 | WEE1 | 0.54555051 |
| 121 | CSK | 0.54141458 |
| 122 | PDPK1 | 0.54137969 |
| 123 | JAK3 | 0.53369124 |
| 124 | PKN1 | 0.53336442 |
| 125 | DYRK1B | 0.51911250 |
| 126 | SIK1 | 0.51660209 |
| 127 | HIPK2 | 0.51602559 |
| 128 | MAPK4 | 0.51215100 |
| 129 | RIPK4 | 0.50543664 |
| 130 | PAK3 | 0.49864554 |
| 131 | PIK3CA | 0.49849653 |
| 132 | CHUK | 0.49835142 |
| 133 | MARK1 | 0.45705889 |
| 134 | CSNK1A1L | 0.45344053 |
| 135 | PRKD2 | 0.45251810 |
| 136 | OXSR1 | 0.44347735 |
| 137 | LCK | 0.43594828 |
| 138 | MYLK | 0.43209337 |
| 139 | FYN | 0.42950848 |
| 140 | PRKCG | 0.42757309 |
| 141 | SGK223 | 0.42246535 |
| 142 | SGK494 | 0.42246535 |
| 143 | TNIK | 0.42138852 |
| 144 | PTK2B | 0.41571924 |
| 145 | CDK15 | 0.39649190 |
| 146 | CDK14 | 0.39570328 |
| 147 | ERN1 | 0.39275372 |
| 148 | CDK18 | 0.37990538 |
| 149 | MAP3K1 | 0.34561246 |
| 150 | STK11 | 0.33584199 |
| 151 | ATR | 0.33509691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.93809943 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.43474454 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.42402080 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.37668650 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.35487531 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.34701723 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.22842488 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.19297903 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.18665687 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.17946707 |
| 11 | Nicotine addiction_Homo sapiens_hsa05033 | 2.14078490 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.09822740 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.05065580 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.01525862 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.92226481 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.91275462 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.88942692 |
| 18 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.84602050 |
| 19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.75379092 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.67963950 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.63124535 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52616889 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51126077 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.49615665 |
| 25 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.49114521 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.47738751 |
| 27 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.45210689 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.43821564 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.42177667 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.40978412 |
| 31 | DNA replication_Homo sapiens_hsa03030 | 1.40399668 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.31553795 |
| 33 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.30662832 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.30483424 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.27859696 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.27570253 |
| 37 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.26094601 |
| 38 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.25056164 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.24391015 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22930277 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21362299 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.18291976 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.17466584 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.17245663 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.16862191 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16491438 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15650836 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.15535846 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14481511 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13285493 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.13017694 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.11864716 |
| 53 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.09721442 |
| 54 | Mismatch repair_Homo sapiens_hsa03430 | 1.09713722 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08137542 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.08088606 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07043852 |
| 58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.07024201 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06912533 |
| 60 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04248985 |
| 61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.03719872 |
| 62 | Cocaine addiction_Homo sapiens_hsa05030 | 1.03184979 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.02820938 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01990930 |
| 65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01258272 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.00359174 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99111282 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.99080587 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.96371384 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.94513246 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.94272806 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.93008790 |
| 73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.92542021 |
| 74 | Taste transduction_Homo sapiens_hsa04742 | 0.92325649 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92163179 |
| 76 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.91362642 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90049387 |
| 78 | Long-term depression_Homo sapiens_hsa04730 | 0.89381238 |
| 79 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88474799 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.88236869 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.87995023 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85786182 |
| 83 | Bile secretion_Homo sapiens_hsa04976 | 0.82635343 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.82564178 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.81417543 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81168402 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.80144511 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79688076 |
| 89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.79677530 |
| 90 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79013972 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78810543 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77164865 |
| 93 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76975868 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72664157 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72285786 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72117285 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71691924 |
| 98 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71341718 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71288457 |
| 100 | Gap junction_Homo sapiens_hsa04540 | 0.71256222 |
| 101 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.71087294 |
| 102 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70984508 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.69790851 |
| 104 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69593376 |
| 105 | Leishmaniasis_Homo sapiens_hsa05140 | 0.68668434 |
| 106 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68432607 |
| 107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68279082 |
| 108 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.67552768 |
| 109 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.67244295 |
| 110 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67064013 |
| 111 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66958598 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66132979 |
| 113 | Lysosome_Homo sapiens_hsa04142 | 0.65468644 |
| 114 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65355620 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64737955 |
| 116 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.64367121 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63914170 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63547361 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62543491 |
| 120 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62453699 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62303723 |
| 122 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61777431 |
| 123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61359194 |
| 124 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.59505963 |
| 125 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58342383 |
| 126 | Axon guidance_Homo sapiens_hsa04360 | 0.57092874 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55345239 |
| 128 | Tuberculosis_Homo sapiens_hsa05152 | 0.55294798 |
| 129 | Prion diseases_Homo sapiens_hsa05020 | 0.55226409 |
| 130 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54811058 |
| 131 | Glioma_Homo sapiens_hsa05214 | 0.54634117 |
| 132 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54170202 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53870851 |
| 134 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52340370 |
| 135 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50229343 |
| 136 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49042361 |
| 137 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48991391 |
| 138 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48502398 |
| 139 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48188917 |
| 140 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46549368 |
| 141 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44603220 |
| 142 | Insulin resistance_Homo sapiens_hsa04931 | 0.43536778 |
| 143 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.42685778 |
| 144 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42614066 |
| 145 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40610531 |
| 146 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40504384 |
| 147 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39535145 |
| 148 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.38417809 |
| 149 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36571128 |
| 150 | Alcoholism_Homo sapiens_hsa05034 | 0.35880753 |

